InflaRx to Host Virtual Capital Markets Day
InflaRx N.V. (Nasdaq: IFRX) will host a virtual Capital Markets Event on November 3, 2026, running from 8:00 AM EST to approximately 9:00 AM EST, with pre-registration required for access. The timing was shifted to better accommodate scheduling and the company's clinical development planning processes in ANCA-associated vasculitis, where its oral C5aR inhibitor izicopan is being positioned to improve on the existing standard of care. Featured speakers include vasculitis expert Dr.
Key figures
- Drug Name
- izicopan
- Event date
- November 3, 2026
- Event window
- 8:00 AM to approximately 9:00 AM EST / 2:00-3:00 PM CET
- C5a neutrophil blockade
- ≥90% blockade of C5a-induced neutrophil activation achieved over the 14-day dosing period
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.